The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 20 October 2003. doi:10.1084/jem.20030305
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 630K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koopman, L. A.
Right arrow Articles by Strominger, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koopman, L. A.
Right arrow Articles by Strominger, J. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© Rockefeller University Press, 0022-1007/2003/10/1201 $5.00
The Journal of Experimental Medicine, Volume 198, Number 8, 1201-1212

Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential

Louise A. Koopman1, Hernan D. Kopcow1, Basya Rybalov1, Jonathan E. Boyson1, Jordan S. Orange1, Frederick Schatz2, Rachel Masch3, Charles J. Lockwood2, Asher D. Schachter4, Peter J. Park4 and Jack L. Strominger1

1 Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138
2 Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT 06510
3 Department of Obstetrics and Gynecology, New York University Medical Center, New York, NY 10016
4 Children's Hospital Informatics Program, Boston, MA 02115

Address correspondence to Louise A. Koopman at her present address Biogen, Inc., 15 Cambridge Center, Rm. 8-530, Cambridge, MA 02142. Phone: (617) 679-3815; Fax: (617) 914-7140; email: louise_koopman{at}biogen.com; or Jack L. Strominger, Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138. Phone: (617) 495-3281; Fax: (617) 496-8351; email: jlstrom{at}fas.harvard.edu

Natural killer cells constitute 50–90% of lymphocytes in human uterine decidua in early pregnancy. Here, CD56bright uterine decidual NK (dNK) cells were compared with the CD56bright and CD56dim peripheral NK cell subsets by microarray analysis, with verification of results by flow cytometry and RT-PCR. Among the ~10,000 genes studied, 278 genes showed at least a threefold change with P <= 0.001 when comparing the dNK and peripheral NK cell subsets, most displaying increased expression in dNK cells. The largest number of these encoded surface proteins, including the unusual lectinlike receptors NKG2E and Ly-49L, several killer cell Ig-like receptors, the integrin subunits {alpha}D, {alpha}X, ß1, and ß5, and multiple tetraspanins (CD9, CD151, CD53, CD63, and TSPAN-5). Additionally, two secreted proteins, galectin-1 and progestagen-associated protein 14, known to have immunomodulatory functions, were selectively expressed in dNK cells.

Key Words: pregnancy • maternal-fetal relations • natural killer cells • gene expression profiling • lymphocyte subsets


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS